A detailed history of Sawtooth Solutions, LLC transactions in Novo Nordisk A S stock. As of the latest transaction made, Sawtooth Solutions, LLC holds 126,153 shares of NVO stock, worth $16.6 Million. This represents 0.36% of its overall portfolio holdings.

Number of Shares
126,153
Previous 123,393 2.24%
Holding current value
$16.6 Million
Previous $11.2 Million 16.3%
% of portfolio
0.36%
Previous 0.36%

Shares

24 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Jan 29, 2024

BUY
$87.78 - $105.45 $242,272 - $291,042
2,760 Added 2.24%
126,153 $13.1 Million
Q3 2023

Oct 19, 2023

BUY
$90.94 - $199.54 $7.88 Million - $17.3 Million
86,650 Added 235.83%
123,393 $11.2 Million
Q2 2023

Jul 26, 2023

BUY
$155.98 - $172.65 $397,904 - $440,430
2,551 Added 7.46%
36,743 $5.95 Million
Q1 2023

Apr 27, 2023

BUY
$132.34 - $159.14 $2.59 Million - $3.11 Million
19,567 Added 133.79%
34,192 $5.44 Million
Q4 2022

Feb 02, 2023

SELL
$102.55 - $135.33 $7,896 - $10,420
-77 Reduced 0.52%
14,625 $1.98 Million
Q3 2022

Oct 12, 2022

SELL
$95.28 - $116.93 $251,158 - $308,227
-2,636 Reduced 15.2%
14,702 $1.47 Million
Q2 2022

Jul 19, 2022

BUY
$103.24 - $121.81 $240,755 - $284,060
2,332 Added 15.54%
17,338 $1.93 Million
Q1 2022

May 20, 2022

SELL
$93.1 - $112.54 $1.26 Million - $1.52 Million
-13,544 Reduced 47.44%
15,006 $1.67 Million
Q4 2021

Feb 11, 2022

BUY
$95.88 - $117.08 $1.5 Million - $1.83 Million
15,661 Added 121.51%
28,550 $3.2 Million
Q3 2021

Nov 09, 2021

BUY
$84.42 - $106.62 $143,514 - $181,254
1,700 Added 15.19%
12,889 $1.24 Million
Q2 2021

Sep 01, 2021

SELL
$67.66 - $84.76 $26,116 - $32,717
-386 Reduced 3.33%
11,189 $937,000
Q1 2021

May 13, 2021

BUY
$67.06 - $75.82 $776,219 - $877,616
11,575 New
11,575 $780,000
Q2 2020

Aug 06, 2020

SELL
$58.54 - $67.94 $234,921 - $272,643
-4,013 Closed
0 $0
Q1 2020

May 15, 2020

SELL
$49.46 - $64.78 $54,999 - $72,035
-1,112 Reduced 21.7%
4,013 $242,000
Q4 2019

Feb 12, 2020

BUY
$49.86 - $58.26 $498 - $582
10 Added 0.2%
5,125 $297,000
Q3 2019

Nov 07, 2019

SELL
$47.54 - $53.43 $1,758 - $1,976
-37 Reduced 0.72%
5,115 $264,000
Q2 2019

Aug 08, 2019

BUY
$46.79 - $52.47 $241,062 - $270,325
5,152 New
5,152 $263,000
Q4 2018

Feb 13, 2019

SELL
$41.54 - $47.25 $213,764 - $243,148
-5,146 Closed
0 $0
Q3 2018

Oct 26, 2018

SELL
$46.76 - $51.24 $34,368 - $37,661
-735 Reduced 12.5%
5,146 $243,000
Q2 2018

Aug 10, 2018

BUY
$44.29 - $50.42 $30,161 - $34,336
681 Added 13.1%
5,881 $271,000
Q1 2018

May 08, 2018

BUY
$48.49 - $58.14 $40,295 - $48,314
831 Added 19.02%
5,200 $256,000
Q4 2017

Feb 13, 2018

SELL
$47.53 - $53.73 $6,226 - $7,038
-131 Reduced 2.91%
4,369 $234,000
Q3 2017

Nov 14, 2017

SELL
$41.15 - $49.22 $756,295 - $904,614
-18,379 Reduced 80.33%
4,500 $217,000
Q2 2017

Aug 09, 2017

BUY
N/A
22,879
22,879 $981,000

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $296B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Sawtooth Solutions, LLC Portfolio

Follow Sawtooth Solutions, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sawtooth Solutions, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sawtooth Solutions, LLC with notifications on news.